Your browser doesn't support javascript.
loading
Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial.
Ritchie, Andrew I; Brill, Simon E; Vlies, Ben H; Finney, Lydia J; Allinson, James P; Alves-Moreira, Luana; Wiseman, Dexter J; Walker, Paul P; Baker, Emma; Elkin, Sarah L; Mallia, Patrick; Law, Martin; Donaldson, Gavin C; Calverley, Peter M A; Wedzicha, Jadwiga A.
Afiliación
  • Ritchie AI; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Brill SE; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Vlies BH; School of Aging and Chronic Disease, University of Liverpool, Liverpool, United Kingdom.
  • Finney LJ; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Allinson JP; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Alves-Moreira L; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Wiseman DJ; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Walker PP; School of Aging and Chronic Disease, University of Liverpool, Liverpool, United Kingdom.
  • Baker E; Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.
  • Elkin SL; Imperial College Healthcare NHS Trust, London, United Kingdom; and.
  • Mallia P; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Law M; Hub for Trials Methodology Research, Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Donaldson GC; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Calverley PMA; School of Aging and Chronic Disease, University of Liverpool, Liverpool, United Kingdom.
  • Wedzicha JA; National Heart and Lung Institute, Imperial College, London, United Kingdom.
Am J Respir Crit Care Med ; 202(4): 549-557, 2020 08 15.
Article en En | MEDLINE | ID: mdl-32267724
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Ciprofloxacina / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials Idioma: En Revista: Am J Respir Crit Care Med Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Ciprofloxacina / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials Idioma: En Revista: Am J Respir Crit Care Med Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido